Literature DB >> 21784397

Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome.

Beverley J Hunt1, Xiao-Xuan Wu, Bas de Laat, Alan A Arslan, Sara Stuart-Smith, Jacob H Rand.   

Abstract

OBJECTIVE: The objective of the study was to investigate whether resistance to annexin A5 anticoagulant activity (AnxA5) occurs in women with histories for obstetric complications of antiphospholipid syndrome (Obs-APS) and whether this correlates with antibody recognition of domain 1 of β2-glycoprotein. STUDY
DESIGN: One hundred thirty-six women with antiphospholipid antibodies, including 70 with histories for Obs-APS and 30 controls, were investigated.
RESULTS: Women with Obs-APS showed resistance to AnxA5 activity (median, 216%; range, 130-282% vs controls; median, 247%; range, 217-283%; P < .0001) and elevated levels of anti-domain I immunoglobulin (Ig) G (optical density: median, 0.056; range, 0.021-0.489 vs median, 0.042; range, 0.020-0.323; P = .002). Those in the lowest tertile of AnxA5 anticoagulant ratios had an odds ratio for Obs-APS of 58.0 (95% confidence interval, 3.3-1021.5). There was an inverse correlation between levels of annexin A5 anticoagulant activity and anti-domain I IgG.
CONCLUSION: Resistance to AnxA5 anticoagulant activity is associated with antibody recognition of domain I of β2-glycoprotein I and identifies a subset of women with histories for Obs-APS. Copyright Â
© 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784397      PMCID: PMC3205287          DOI: 10.1016/j.ajog.2011.06.019

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  21 in total

1.  Role of the M2 haplotype within the annexin A5 gene in the occurrence of pregnancy-related venous thromboembolism.

Authors:  Elvira Grandone; Giovanni Tiscia; Donatella Colaizzo; Elena Chinni; Daniela Pisanelli; Valeria Bafunno; Maurizio Margaglione
Journal:  Am J Obstet Gynecol       Date:  2010-11       Impact factor: 8.661

2.  Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses.

Authors:  Jacob H Rand; Alan A Arslan; Xiao-Xuan Wu; Rosemary Wein; Jeanine Mulholland; Manish Shah; Waander L van Heerde; Chris P Reutelingsperger; Charles J Lockwood; Edward Kuczynski
Journal:  Am J Obstet Gynecol       Date:  2006-01       Impact factor: 8.661

3.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

4.  Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis.

Authors:  X-X Wu; S S Pierangeli; J H Rand
Journal:  J Thromb Haemost       Date:  2006-01       Impact factor: 5.824

5.  Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5.

Authors:  Bas de Laat; Xiao-Xuan Wu; Menno van Lummel; Ronald H W M Derksen; Philip G de Groot; Jacob H Rand
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

6.  Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation.

Authors:  E Vogt; A K Ng; N S Rote
Journal:  Am J Obstet Gynecol       Date:  1997-10       Impact factor: 8.661

7.  IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis.

Authors:  Bas de Laat; Ronald H W M Derksen; Rolf T Urbanus; Philip G de Groot
Journal:  Blood       Date:  2004-10-26       Impact factor: 22.113

8.  Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome.

Authors:  J G Hanly; S A Smith
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

9.  Antiphospholipid antibody syndrome: rapid, sensitive, and specific flow cytometric assay for determination of anti-platelet phospholipid autoantibodies.

Authors:  Aaron Tomer
Journal:  J Lab Clin Med       Date:  2002-03

10.  Annexin V is critical in the maintenance of murine placental integrity.

Authors:  X Wang; B Campos; M A Kaetzel; J R Dedman
Journal:  Am J Obstet Gynecol       Date:  1999-04       Impact factor: 8.661

View more
  7 in total

1.  Prediction of Antiphospholipid syndrome using Annexin A5 competition assay in patients with SLE.

Authors:  Avital Avriel; Stela Fleischer; Michael Friger; Ora Shovman; Gal Neuman; Yehuda Shoenfeld; Mahmoud Abu-Shakra
Journal:  Clin Rheumatol       Date:  2016-10-04       Impact factor: 2.980

Review 2.  Insights into the pathophysiology of the antiphospholipid syndrome provided by atomic force microscopy.

Authors:  Anthony S Quinn; Xiao-Xuan Wu; Jacob H Rand; Douglas J Taatjes
Journal:  Micron       Date:  2012-03-23       Impact factor: 2.251

3.  Restriction of the Global IgM Repertoire in Antiphospholipid Syndrome.

Authors:  Shina Pashova; Lubomir Balabanski; Gabriel Elmadjian; Alexey Savov; Elena Stoyanova; Velizar Shivarov; Peter Petrov; Anastas Pashov
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

Review 4.  Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?

Authors:  Yu Zuo; Medha Barbhaiya; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2018-09-10       Impact factor: 4.592

5.  Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activity.

Authors:  Jacob H Rand; Xiao-Xuan Wu; Elaine Y Lin; Alexander Griffel; Philip Gialanella; John C McKitrick
Journal:  mBio       Date:  2012-03-13       Impact factor: 7.867

Review 6.  Recent advances in understanding antiphospholipid syndrome.

Authors:  Maria Laura Bertolaccini; Giovanni Sanna
Journal:  F1000Res       Date:  2016-12-22

Review 7.  Renal Involvement in Antiphospholipid Syndrome.

Authors:  Alonso Turrent-Carriles; Juan Pablo Herrera-Félix; Mary-Carmen Amigo
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.